DOTA-Octreotide TFA
DOTA-Octreotide TFA is a bifunctional conjugate combining the chelator DOTA with the somatostatin analog Octreotide. It is used in cancer research to synthesize radiolabeled conjugates for targeted imaging and therapy, enabling both in vitro receptor binding studies and in vivo preclinical evaluation of somatostatin receptor-positive tumors.
Product Specifications
Field of Research
Immunology & Inflammation; Pharmacology & Drug Discovery
Molecular Weight
1519.66
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog